Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ad-Free, Unlimited access)​
NO CREDIT CARD REQUIRED
BDMDW
Upturn stock ratingUpturn stock rating

Baird Medical Investment Holdings Limited (BDMDW)

Upturn stock ratingUpturn stock rating
$0.1
Last Close (24-hour delay)
upturn advisory
PASS
  • BUY Advisory
  • SELL Advisory (Profit)​
  • SELL Advisory (Loss)​
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock infoUpturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK

Upturn Advisory Summary

08/14/2025: BDMDW (1-star) is currently NOT-A-BUY. Pass it for now.

Upturn Star Rating

rating

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

Number of Analysts

rating

0 Analysts rated it

Very few follow this stock; limited insights, higher-risk early investing.

Analysis of Past Performance

Type Stock
Historic Profit -70.83%
Avg. Invested days 31
Today’s Advisory PASS
Upturn Star Rating Upturn stock ratingUpturn stock rating
Upturn Advisory Performance Upturn Advisory Performance 1.0
Stock Returns Performance Upturn Returns Performance 1.0
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 08/14/2025

Key Highlights

Company Size ETF
Market Capitalization 0 USD
Price to earnings Ratio -
1Y Target Price -
Price to earnings Ratio -
1Y Target Price -
Volume (30-day avg) -
Beta -0.7
52 Weeks Range 0.02 - 0.20
Updated Date 06/3/2025
52 Weeks Range 0.02 - 0.20
Updated Date 06/3/2025
Dividends yield (FY) -
Basic EPS (TTM) -

Earnings Date

Report Date -
When -
Estimate -
Actual -

Profitability

Profit Margin 37.96%
Operating Margin (TTM) 38.74%

Management Effectiveness

Return on Assets (TTM) -
Return on Equity (TTM) -

Valuation

Trailing PE -
Forward PE -
Enterprise Value -
Price to Sales(TTM) -
Enterprise Value -
Price to Sales(TTM) -
Enterprise Value to Revenue -
Enterprise Value to EBITDA -
Shares Outstanding -
Shares Floating 10638416
Shares Outstanding -
Shares Floating 10638416
Percent Insiders -
Percent Institutions -

ai summary icon Upturn AI SWOT

Baird Medical Investment Holdings Limited

stock logo

Company Overview

overview logo History and Background

Baird Medical Investment Holdings Limited focuses on medical device and technology investments. Precise founding details and history are scarce in publicly available information. It appears to be a relatively newer entity concentrating on the Chinese market.

business area logo Core Business Areas

  • Medical Device Investments: Investing in medical device companies, including development, production, and distribution of medical devices.
  • Healthcare Technology: Focus on healthcare technology companies.
  • Distribution and Sales: Engaged in the sales and distribution of various medical products.

leadership logo Leadership and Structure

Information on specific leadership and detailed organizational structure is limited in publicly available resources. It likely has a hierarchical structure with investment managers and operational teams.

Top Products and Market Share

overview logo Key Offerings

  • Medical Imaging Devices: Potentially involved in the distribution or investment of medical imaging devices. Specific market share data unavailable. Competitors: GE Healthcare, Siemens Healthineers, Philips.
  • Surgical Instruments: Potentially involved in surgical instruments. Specific market share data unavailable. Competitors: Medtronic, Johnson & Johnson, Stryker.

Market Dynamics

industry overview logo Industry Overview

The medical device industry is experiencing growth driven by an aging population, technological advancements, and increasing healthcare spending. There is a high degree of competition and regulatory oversight.

Positioning

Baird Medical Investment Holdings Limited aims to capitalize on the growth in the Chinese medical device market. Its competitive advantage would depend on successful investments and partnerships.

Total Addressable Market (TAM)

The global medical device market is estimated to be in the hundreds of billions of USD. Baird Medical Investment Holdings Limited is positioned to capture a portion of this market through its investments and operations. Exact TAM and positioning not readily available.

Upturn SWOT Analysis

Strengths

  • Access to Chinese medical device market
  • Potential for high growth in the healthcare sector
  • Investment expertise

Weaknesses

  • Limited public information on specific performance
  • Dependence on investment success
  • Smaller scale compared to established competitors

Opportunities

  • Increasing demand for medical devices in China
  • Technological advancements in healthcare
  • Partnerships with leading medical device companies

Threats

  • Regulatory changes in China
  • Competition from established medical device companies
  • Economic downturn affecting healthcare spending

Competitors and Market Share

competitor logo Key Competitors

  • Medtronic (MDT)
  • Johnson & Johnson (JNJ)
  • Siemens Healthineers (SIE.DE)

Competitive Landscape

Baird Medical Investment Holdings Limited faces significant competition from well-established multinational medical device companies. Its advantage lies in its focus on the Chinese market and potential for strategic investments. Limited publicly available financial info makes a full comparison difficult.

Growth Trajectory and Initiatives

Historical Growth: Historical Growth is not readily available for public analysis.

Future Projections: Future Projections is not readily available for public analysis.

Recent Initiatives: Recent Initiatives information is not readily available for public analysis.

Summary

Baird Medical Investment Holdings Limited appears to be an investment holding company focusing on the growing Chinese medical device market. Its success hinges on strategic investments and navigating the competitive landscape. The company faces significant competition from established players and regulatory hurdles. Limited availability of financial information makes thorough evaluation difficult.

Peer Comparison

Sources and Disclaimers

Data Sources:

  • Company filings (if available)
  • Industry reports
  • Market research reports
  • News articles

Disclaimers:

The information provided is based on limited publicly available data and should not be considered financial advice. Market conditions and company performance may change over time.

Upturn AI SummarizationUpturn AI Summarization AI Summarization is directionally correct and might not be accurate.

Upturn AI SummarizationUpturn AI Summarization Summarized information shown could be a few years old and not current.

Upturn AI SummarizationUpturn AI Summarization Fundamental Rating based on AI could be based on old data.

Upturn AI SummarizationUpturn AI Summarization AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.

About Baird Medical Investment Holdings Limited

Exchange NASDAQ
Headquaters -
IPO Launch date 2024-10-02
Chairwoman of the Board of Directors & CEO Ms. Haimei Wu
Sector Healthcare
Industry Medical Devices
Full time employees 143
Full time employees 143

Baird Medical Investment Holdings Limited, together with its subsidiaries, engages in research and development, manufacturing, and sales of microwave ablation and other medical devices in the People's Republic of China. It offers microwave ablation apparatus and needles, as well as microwave ablation apparatus approved for the treatment of live cancer and thyroid nodules, long microwave ablation needles, and fine microwave ablation needles through third-party distributors. Baird Medical Investment Holdings Limited was founded in 2012 and is based in Guangzhou, China.